Psychopharmacology of Pediatric Anxiety Disorders: A Narrative Review

被引:6
|
作者
Amray, Afshan N. [1 ,2 ]
Munir, Khurram [3 ]
Jahan, Nusrat [4 ]
Motiwala, Fatima B. [5 ]
Naveed, Sadiq [6 ]
机构
[1] Dow Univ Hlth Sci, Dow Med Coll, Med, Karachi, Pakistan
[2] Dow Univ Hlth Sci, Civil Hosp Karachi, Karachi, Pakistan
[3] Sheikh Zayed, Physiol, Rahim Yar Khan, Pakistan
[4] Rush Univ, Internal Med, Med Ctr, Chicago, IL 60612 USA
[5] Texas Tech Univ, Hlth Sci Ctr, Psychiat, Midland, TX USA
[6] Univ Kansas, Med Ctr, Psychiat, Kansas City, MO USA
关键词
anxiety; youth; psychopharmacology; PREPUBERTAL CHILDREN; CONTROLLED-TRIAL; SOCIAL PHOBIA; ADOLESCENTS; CHILDHOOD; PLACEBO; SERTRALINE; VENLAFAXINE; PAROXETINE; CLONAZEPAM;
D O I
10.7759/cureus.5487
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anxiety disorders are common among children and adolescents; almost one-third of this population has an anxiety disorder. The most common anxiety disorders in this population are specific phobia (19.3%), social anxiety disorder/social phobia (9.1 %), and separation anxiety disorder (7.6 %). Pediatric anxiety disorders are often associated with poor psychosocial functioning, academic underachievement, learning difficulties, substance abuse, relationship problems, and suicide behaviors. Psychotherapy, particularly cognitive behavioral therapy as a stand-alone treatment or in combination with medication, is found to be efficacious in the treatment of various anxiety disorders. The early recognition and treatment of anxiety disorders result in better long-term outcomes in children and adolescents. This article summarizes the evidence-based pharmacologic treatments for anxiety disorders in youth, including social anxiety disorder generalized anxiety disorder, separation anxiety disorder, and panic disorder.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Genetics of Pediatric Anxiety Disorders
    Sakolsky, Dara J.
    McCracken, James T.
    Nurmi, Erika L.
    [J]. CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2012, 21 (03) : 479 - +
  • [42] Treatment of pediatric anxiety disorders
    Rapp, Amy
    Dodds, Alice
    Walkup, John T.
    Rynn, Moira
    [J]. CHILDHOOD ONSET DEVELOPMENTAL DISORDERS, 2013, 1304 : 52 - 61
  • [43] Neurobiology of Pediatric Anxiety Disorders
    Strawn J.R.
    Dominick K.C.
    Patino L.R.
    Doyle C.D.
    Picard L.S.
    Phan K.L.
    [J]. Current Behavioral Neuroscience Reports, 2014, 1 (3) : 154 - 160
  • [44] ANXIETY DISORDERS IN A PEDIATRIC SAMPLE
    BENJAMIN, RS
    COSTELLO, EJ
    WARREN, M
    [J]. JOURNAL OF ANXIETY DISORDERS, 1990, 4 (04) : 293 - 316
  • [45] Psychopharmacology of autism spectrum disorders: A selective review
    Mohiuddin, Sarah
    Ghaziuddin, Mohammad
    [J]. AUTISM, 2013, 17 (06) : 645 - 654
  • [46] Screening for Pediatric Anxiety Disorders
    Walkup, John T.
    Green, Cori M.
    Strawn, Jeffrey R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (14): : 1399 - 1401
  • [47] Review of Evidence-Based Psychotherapies for Pediatric Mood and Anxiety Disorders
    Verdeli, Helen
    Mufson, Laura
    Lee, Lena
    Keith, Jessica A.
    [J]. CURRENT PSYCHIATRY REVIEWS, 2006, 2 (03) : 395 - 421
  • [48] Challenges in developing drugs for pediatric CNS disorders: A focus on psychopharmacology
    Grabb, Margaret C.
    Gobburu, Jogarao V. S.
    [J]. PROGRESS IN NEUROBIOLOGY, 2017, 152 : 38 - 57
  • [49] Perioperative management in pediatric domino liver transplantation for metabolic disorders: A narrative review
    Uslu, Ahmed
    Cekmen, Nedim
    Torgay, Adnan
    Haberal, Mehmet
    [J]. PEDIATRIC ANESTHESIA, 2024,
  • [50] Psychopharmacology and the power of narrative
    Appelbaum, PS
    [J]. AMERICAN JOURNAL OF BIOETHICS, 2005, 5 (03): : 48 - 49